ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Ids

Ids (MLIDS)

0.49
0.00
(0.00%)
Closed October 12 11:30AM

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
0.49
Bid
0.25
Ask
0.48
Volume
0.00
0.00 Day's Range 0.00
0.30 52 Week Range 0.68
Market Cap
Previous Close
0.49
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
380
Shares Outstanding
4,796,393
Dividend Yield
-
PE Ratio
-3.64
Earnings Per Share (EPS)
-0.13
Revenue
1.79M
Net Profit
-646k

About Ids

Sector
Computers & Software-whsl
Industry
Computers & Software-whsl
Headquarters
Lyon, Rhone, Fra
Founded
-
Ids is listed in the Computers & Software-whsl sector of the Euronext with ticker MLIDS. The last closing price for Ids was 0.49 €. Over the last year, Ids shares have traded in a share price range of 0.30 € to 0.68 €.

Ids currently has 4,796,393 shares outstanding. The market capitalization of Ids is 2.35 € million. Ids has a price to earnings ratio (PE ratio) of -3.64.

MLIDS Latest News

IDS RESULTATS 2023

IDS RESULTATS 2023 COMMUNIQUE DE PRESSE / Le 20 Mai 2024         Résultats 2023 L’année 2023 a été une année de réorganisation, de restructuration et de redynamisation. Un nouveau Directeur...

IDS RESULTATS 2020

IDS RESULTATS 2020 COMMUNIQUE DE PRESSE / Le 7 Mai 2021          Résultats 2020 impactés par la crise sanitaire Le Conseil d’administration d’IDS s’est réuni le 5 mai 2021 et a arrêté les...

IDS Résultats 2019 et Perspectives 2020

IDS Résultats 2019 et Perspectives 2020 COMMUNIQUE DE PRESSE /  Le  5 Juin 2020             Résultats 2019 et Perspectives 2020 IDS a subi une baisse d’activité en 2019 principalement due aux...

IDS SA : Résultats 2018 et Perspectives 2019

COMMUNIQUE DE PRESSE -Le 18 Mars 2019 Résultats 2018 et Perspectives 2019 IDS a atteint de nouveau en 2018 un bon niveau d'activité conforme à ses performances structurelles avec une...

IDS SA : Résultats 2017 et Perspectives 2018

COMMUNIQUE DE PRESSE -Le 19 Juin 2018 Résultats 2017 et Perspectives 2018 L'activité de la Société a subi un net recul de 17 %. Sur son marché d'intégration et de production de données...

IDS SA : Résultats 2015 et Perspectives 2016

COMMUNIQUE DE PRESSE -Le 31 Mai 2016                                    Résultats 2015 et Perspectives 2016 L'exercice 2015 a été marqué par une stabilité accompagnée d'une forte...

IDS SA : Résultats 2014 et Perspectives 2015

COMMUNIQUE DE PRESSE -Le 17 Avril 2015Résultats 2014 et Perspectives 2015 L'exercice 2014 a été marqué par une compétition accrue sur les contrats d'intégration et de production de...

IDS SA : Résultats 2013 et Perspectives 2014

  COMMUNIQUE DE PRESSE - Le 29 Avril 2014Résultats 2013 et Perspectives 2014 L'exercice 2013 a été marqué par une consolidation de l'activité d'IDS sur son métier...

IDS SA : Résultats 2012 et Perspectives 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  COMMUNIQUE DE PRESSE - Le 30 Mai 2013Résultats...

IDS SA : Résultats 2012 et Perspectives 2013

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;}  COMMUNIQUE DE PRESSE - Le 30 Mai 2012 Résultats...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.490.490.4900DE
40.11229.62962962960.3780.490.3782980.49DE
120.1963.33333333330.30.50.33800.45049842DE
260.17254.08805031450.3180.50.316350.39064495DE
52-0.19-27.94117647060.680.680.310320.37561151DE
156-0.11-18.33333333330.60.720.314730.55690915DE
260-0.3-37.97468354430.790.9050.315200.61009979DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALRPDRapid Nutrition
0.0746 €
(28.18%)
15.67M
ALOKWGroupe Okwind SA
8.20 €
(17.14%)
15.15k
ALTHOMetavisio (Thomson Computing)
0.397 €
(16.42%)
1.34M
IBABIon Beam Applications SA
15.00 €
(14.16%)
178.95k
ALMEXMexedia SPA
6.80 €
(13.33%)
64
MLWEYWeya
0.02 €
(-95.45%)
10
ALAVEAventador
0.001 €
(-28.57%)
35.75M
ALDVAlliance Developpement Capital Siic
0.06 €
(-19.46%)
280.26k
GNROGeNeuro SA
0.0724 €
(-18.65%)
28.22k
MLGRCGroupe Carnivor
16.80 €
(-16.00%)
12
BCPBanco Comercial Portugues SA
0.4333 €
(3.51%)
141.92M
ALAVEAventador
0.001 €
(-28.57%)
35.75M
ALDOLDolfines
0.0006 €
(-14.29%)
29.46M
ALRPDRapid Nutrition
0.0746 €
(28.18%)
15.67M
ALNRGEnergisme SA
0.0061 €
(7.02%)
12.85M

Discussion

View Full Feed
ssc ssc 3 minutes ago
Spin, spin, spin. Twist, squirm, twist, squirm, twist squirm. Another new version of a worn out, unproven narrative filled with if's and would's. When management chooses to keep investors in the dark for 7 years, it's understandable why that's all ya got. That and 400 million shares at a price n
ERHE
CaptBeer CaptBeer 3 minutes ago
Gotta love those Auzie's! Did you notice they changed the price from $154 to $32? That should sell like hotcakes!
AMRN
i_dont_know i_dont_know 3 minutes ago
Interesting to see what his successor is doing if he gets the job in 20 years *lol*
BLPG
tredenwater2 tredenwater2 3 minutes ago
My points are that companies applying for EMA and FDA approval typically have 2 properly powered P3 trials.

Does proof of genomic activation and RNA data not help our trial data above and beyond the normal proof of work concept for what is statistically significant or not?
AVXL
Gmenfan Gmenfan 4 minutes ago
Worthless... the word of the day for this administration.

Actually the word every day!

“Luxury shopping and now dinner at Nobu?” Rep. Dan Bishop (R-NC) told The Post in disbelief. “Mayorkas seems to care far more about keeping up with the Kardashians than any sort of
Gmenfan Gmenfan 4 minutes ago
Worthless... the word of the day for this administration.

Actually the word every day!

“Luxury shopping and now dinner at Nobu?” Rep. Dan Bishop (R-NC) told The Post in disbelief. “Mayorkas seems to care far more about keeping up with the Kardashians than any sort of
getmoreshares getmoreshares 4 minutes ago
this week info:UP 141.67%, pps gain 0.017
ZHUD
CaptBeer CaptBeer 5 minutes ago
They would probably need a short bioequivalence trial similar to MARINE.
AMRN
Kap10jak Kap10jak 5 minutes ago
If you pay 1 dollar for a stock and it splits the next day you have 2 shares and you only paid a dollar so each share cost you fitty cent. So to that guy you need to divide the original cost by number of splits to find out what he paid per share for all the shares he now owns.
NWBO
Gmenfan Gmenfan 6 minutes ago
Herschel Walker to Barack Obama: ‘Telling Us to Vote Based on Color Is a Step Backward’
WARNER TODD HUSTON 11 Oct 2024 3:03

Former Georgia candidate for U.S. Senate Herschel Walker blasted Barack Obama for sending black people backward in equality by demanding they vote based o
TheFinalCD TheFinalCD 7 minutes ago
https://x.com/pulte/status/1845069073433923951
Gmenfan Gmenfan 7 minutes ago
Herschel Walker to Barack Obama: ‘Telling Us to Vote Based on Color Is a Step Backward’
WARNER TODD HUSTON 11 Oct 2024 3:03

Former Georgia candidate for U.S. Senate Herschel Walker blasted Barack Obama for sending black people backward in equality by demanding they vote based o
getmoreshares getmoreshares 7 minutes ago
why? too much feces on the streets?
Gmenfan Gmenfan 8 minutes ago
A worthless piece of shlt as is the rest the the current administration!
VortexFortress8 VortexFortress8 9 minutes ago
At least you are being honest..but i think rocks are a little too much for you..maybe you should go back to the powder..
HIRU
Gmenfan Gmenfan 10 minutes ago
Hi Bull. Out of curiosity, what do you do with the fronds and the cut up chunks of trees?

BTW that's quite an inventory of cordless power tools you have. I have many of the same but not as diverse of a collection.
straightword straightword 10 minutes ago
History shows that nothing will happen as a result of this. Get back to me when they get financial judgements that are in-line with the "billions and billions of ongoing" infringements that the CEO has spoken about. If not then it's a complete failure and confirmation that the patents aren't worth n
VPLM
sharpie510 sharpie510 11 minutes ago
Thanks Doc logic. So what does this mean for when the clock started? Is the clock start date when validation happens (January 24, 2024) or when confirmation happens (March 7, 2024)?
NWBO
Investor082 Investor082 11 minutes ago
Yup. Flaskworks carrot has been dangled so the social media army have conceded that no big pharma partnership is coming anytime soon!
NWBO
TrendTrade2016 TrendTrade2016 14 minutes ago
TOO BAD YOU DON'T SHORT
DWTX
trunkmonk trunkmonk 14 minutes ago
cant open and only have 1 post. any take away is appreciated.
FNMA
tm3141 tm3141 14 minutes ago
it is available
FNMA
Investor082 Investor082 15 minutes ago
Cant agree more. Given this history, it’s not surprising that no major institutional investors will ever touch this company. Always complaining!
NWBO

Your Recent History

Delayed Upgrade Clock